Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
China Traditional Chinese Medicine Holdings Co ( (HK:0570) ) has provided an announcement.
China Traditional Chinese Medicine Holdings Co. Limited announced that its subsidiary, Tongjitang Pharmaceutical, has entered into agreements for the construction of an alcohol extraction workshop. The project involves purification engineering and wastewater pretreatment, with services provided by Pharmengin and Wuhan Hongli. These agreements are considered connected transactions under the Hong Kong Stock Exchange Listing Rules, as Pharmengin is a subsidiary of CNPGC, a major shareholder of the company. The transactions are exempt from independent shareholder approval but require announcement and reporting due to their size.
The most recent analyst rating on (HK:0570) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Traditional Chinese Medicine Holdings Co stock, see the HK:0570 Stock Forecast page.
More about China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited operates in the traditional Chinese medicine industry, focusing on the production and distribution of herbal medicines and related health products. The company is known for its commitment to integrating traditional Chinese medicine with modern pharmaceutical practices, catering to both domestic and international markets.
YTD Price Performance: -1.40%
Average Trading Volume: 30,649,666
Technical Sentiment Signal: Sell
Current Market Cap: HK$11.03B
See more insights into 0570 stock on TipRanks’ Stock Analysis page.